Reminder: CRI Abstract Deadline is March 14

["

The AACI CRI Steering Committee is currently soliciting abstracts<\/a> for the 14th Annual AACI CRI Meeting<\/a>. This year’s meeting theme will focus on innovation in cancer clinical research. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers.<\/p>\n\n

Updates to the 2022 Submission Process<\/strong><\/p>\n\n

This year, AACI has increased the number of abstract submission categories to eight. The categories will be Regulatory; Quality Assurance, Remote Monitoring and Auditing; Finance\/CCSG\/PRMS; Trial Recruitment & Community Outreach and Engagement; Trial Start-up; Clinical Operations; Investigator-Initiated Trials; and Training and Career Development. 
\n
\nAs in 2021, abstracts will be submitted online. The online submission tool opened in February. A